Answers are grounded in this paper and cite their sources.
Experimental study demonstrates targeting kita improves image-based screening in zebrafish larvae, suggesting an unbiased control strategy for functional genomics.
With thousands of loci identified by genome-wide association studies for complex traits, there is a need for in vivo model systems that can reliably and quickly infer the role of large numbers of candidate genes. CRISPR/Cas9-based functional screens in F 0 zebrafish represent such a system. However, negative controls used so far – including scrambled guide RNAs (gRNAs), inactivated Cas9, and sham injections – do not elicit the same cellular and organismal responses as mutagenesis by CRISPR/Cas9, and may fuel biased conclusions. Here, we show that targeting kita facilitates efficient optical pre-screening for successful mutagenesis, higher quality imaging data, and efficient classification of cases and controls. We identified and tested two gRNAs that target kita with similarly high mutagenic efficiency and effects on pigmentation, and are free from off-target effects or major effects on cardiometabolic traits. We propose several approaches that will result in valid, unbiased conclusions.
No takes yet. Share an insight, caveat, or question.
Mazzaferro et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: